Form 4: Stoke Therapeutics COO Huw M. Nash Reports Stock Transactions
SEC Form 4 Filing
Huw M. Nash, COO & CBO of Stoke Therapeutics, reports acquisition and disposal of common stock and vesting of restricted stock units.
Summary
- On March 15, 2024, Huw M. Nash acquired 13,100 shares of common stock through the vesting of restricted stock units and also acquired 2,345 shares pursuant to the Issuer's Employee Stock Purchase Plan.
- On March 19, 2024, Nash disposed of 4,116 shares of common stock at a weighted average price of $6.0986 to cover tax withholding liabilities.
- Following these transactions, Nash directly owns 11,329 shares of common stock.
- Nash also holds 39,300 restricted stock units, each representing a right to receive one share of common stock, vesting annually beginning March 15, 2024.
Sentiment
Score: 5
Explanation: The document reflects standard insider trading activity related to compensation and tax obligations, with no indication of unusual or concerning behavior. Therefore, the sentiment is neutral.
Future Outlook
The reporting person's holdings will change as restricted stock units continue to vest annually, contingent on continued service to the Issuer.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, providing transparency to investors about the executive's stake in the company. It is a standard practice for publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency regarding insider transactions.
- The vesting schedule of the restricted stock units (1/4th annually) is a common vesting structure in the biotechnology industry for employee retention.
- The sale of shares to cover tax liabilities associated with RSU vesting is also a common practice among executives.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider ownership.
- The sale of shares to cover tax liabilities has a minimal impact on the market.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Acquisition of 13,100 shares through RSU vesting and acquisition of 2,345 shares through the Employee Stock Purchase Plan. |
| 03/15/2024 | Vesting start date for restricted stock units. |
| 03/19/2024 | Sale of 4,116 shares to cover tax liabilities. |
| 03/15/2027 | Expiration date for restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.